|
⚲
|
| Keyboard |
| Richard Robb | |
|---|---|
| Firm | |
| Address | 680 Fifth Avenue 11th Floor New York, NY 10019 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| First Ammonia Inc | 021-520735 | Director | 4.0 M | ||
| CRC Single Investor Fund XXIII LLC | 021-518779 | Executive Officer | |||
| CRC Single Investor Fund XIX LLC | 021-514638 | Executive Officer | 150.0 M | ||
| CRC CRF V Europe - Sub-Fund I | 021-400027 | Promoter | 128.9 M | ||
| XEME Biopharma Inc | 021-284014 | Executive Officer | of 10.0 M |
||
| Wellright LLC | 021-226491 | Director | 0.6 M of 1.0 M |
||
| EKOS Corp | 021-46846 | Director | 5.5 M of 5.5 M |
||
| Amnis Corp | 021-62596 | Director | 0.9 M of 1.5 M |
||
| Christofferson Robb & Company LLC | |||||
| CRC Single Investor Fund XXII LP | 021-484451 | Director | 200.5 M | ||
| CRC Single Investor Fund XII LP | 021-300442 | Director | 13.7 M | 1.9 M | |
| CRC Capital Release Fund III Ltd | 021-300444 | Director | 5.0 M | 51.1 M | |
| CRC Bond Opportunity Trading Fund LP | 021-274143 | Executive Officer | 756.3 M | 1,296.4 M | |
| CRC Liquid Strategies Fund LP | 021-155937 | Executive Officer | 4.8 M | ||